A Mini Review on the Protective Effect of Lignans for the Treatment of Neurodegenerative Disorders
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chemoprotective Effects of Flaxseed Lignans Enterodiol And
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Texas A&M Repository CHEMOPROTECTIVE EFFECTS OF FLAXSEED LIGNANS ENTERODIOL AND ENTEROLACTONE IN NON-TRANSFORMED COLONOCYTES A Thesis by CHRISTINA ALISON CURRY Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Chair of Committee, Clinton Allred Committee Members, Joseph Awika Jenna Anding Head of Department, Boon Chew December 2015 Major Subject: Nutrition Copyright 2015 Christina Alison Curry ABSTRACT Previous epidemiological studies have shown that colon cancer incidence is correlated to diet and estrogen status. Phytoestrogens are molecules with similar structures to estrogen that occur naturally in plants. There is in vitro and in vivo evidence that phytoestrogens in the diet can inhibit carcinogenesis. The phytoestrogenic mammalian lignans enterolactone (EL) and enterodiol (ED) in flaxseed have been shown to be effective in decreasing tumor incidence in carcinogenic models, but there is little data regarding their effects in non-malignant cells. The following studies used a non- transformed cell line of young adult mouse colonocytes (YAMC) to determine the protective effects of ED and EL in chemoprevention. Our results demonstrate that low levels of EL (1µM) and ED (5µM) are effective at significantly reducing cell growth and increasing apoptosis. These treatments also regulated transcription via significant differences in gene levels related to apoptosis and cell cycle progression. The data collected demonstrate some of the physiological effects of EL and ED on the cellular and molecular level. -
(12) Patent Application Publication (10) Pub. N0.: US 2014/0221426 A1 Gerk Et Al
US 20140221426A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2014/0221426 A1 Gerk et al. (43) Pub. Date: Aug. 7, 2014 (54) SELECTIVE METABOLIC APPROACH TO A61K 31/216 (2006.01) INCREASING ORAL BIOAVAILABILITY OF A61K 31/09 (2006.01) PHENYLEPHRINE AND OTHER PHENOLIC A61K 31/05 (2006.01) BIOACTIVITIES A61K 31/353 (2006.01) A61K 31/4525 (2006.01) (71) Applicant: VIRGINIA COMMONWEALTH A61 K 31/3 75 (2006.01) UNIVERSITY, Richmond, VA (US) A61K 31/121 (2006.01) _ _ _ (52) US. Cl. (72) Inventorsl Ph_lll_lP M- Gerk’ Rthmond, VA (Us); CPC ........... .. A61K 31/137 (2013.01); A61K 31/3 75 Wllllam H- Fa", R10hm°nda VA (Us); (2013.01); A61K 31/235 (2013.01); A61K J"sellh K- thter’ Rlchmond, VA (Us) 31/11 (2013.01); A61K 31/085 (2013.01); _ A61K 31/121 (2013.01); A61K 31/09 (21) APP1~ NO" 14/345,689 (2013.01); A61K31/05 (2013.01); A61K . _ 31/353 (2013.01);A61K31/4525 (2013.01); (22) PCT Filed. Sep. 27, 2012 A61K31/216 (201301) USPC ......... .. 514/321' 514/653' 514/474' 514/544' ( 86 ) PCT N 0 .: PCT/U52012/057588 ’ ’ 514/456;’ 514/532’ § 371 (0X1), Related US“ Application Data Presystemic metabolism in intestine of bioactives such as (60) Provisional application No. 61/539,530, ?led on Sep. phenylephrine 1? avoided by administering a Sllbject (human 27, 2011, provisional application No. 61/544,396, 0r 21111111211) the bloactlve(e-g-,Pheny1ephr1ne)1n comblnatlon ?led on Oct 7, 201 1_ With one or more inhibitors of sulfation (e.g., sulfotransferase enzymes aka SULTs). -
Phytoestrogens : Daidzein, Enterodiol, Enterolactone, Equol, Geinstein, O-Desmethylangolensin Matrix: Urine Method: HPLC-ESI-MS/MS Method No: 4069.03
Laboratory Procedure Manual Analyte: Phytoestrogens : Daidzein, Enterodiol, Enterolactone, Equol, Geinstein, O-Desmethylangolensin Matrix: Urine Method: HPLC-ESI-MS/MS Method No: 4069.03 Revised: March 2018 as performed by: Nutritional Biomarkers Branch (NBB) Division of Laboratory Sciences (DLS) National Center for Environmental Health (NCEH) contact: James L. Pirkle, M.D., Ph.D. Director, Division of Laboratory Sciences Important Information for Users CDC periodically refines these laboratory methods. It is the responsibility of the user to contact the person listed on the title page of each write-up before using the analytical method to find out whether any changes have been made and what revisions, if any, have been incorporated. Phytoestrogen NHANES 2013-2014 This document details the Lab Protocol for testing the items listed in the following table. This method file describes measurements of U1PHYTO_H_R and U2PHYTO_H_R. One method was used to measure both the 24 hour urine phytoestrogen, 1st urine collection and 24 hour urine phytoestrogen, 2nd urine collection. However, these results are released as 2 separate data files. Variable File Name SAS Label (and SI units) Name Daidzein, Urine 1st collection UR1DAZ (ng/mL) o-Desmethylangolensin, Urine 1st UR1DMA Collection (ng/mL) UR1EQU Equol, Urine 1st Collection (ng/mL) Enterodiol, Urine 1st Collection UR1ETD (ng/mL) Enterolactone, Urine 1st Collection UR1ETL (ng/mL) Genistein, Urine 1st Collection UR1GNS (ng/mL) U1PT_H_R Daidzein, Urine 2nd collection U2PT_H_R UR2DAZ (ng/mL) o-Desmethylangolensin, Urine 2nd UR2DMA Collection (ng/mL) UR2EQU Equol, Urine 2nd Collection (ng/mL) Enterodiol, Urine 2nd Collection UR2ETD (ng/mL) Enterolactone, Urine 2nd Collection UR2ETL (ng/mL) Genistein, Urine 2nd Collection UR2GNS (ng/mL) 2 of 54 Phytoestrogen NHANES 2013-2014 1. -
Article 1. General Provisions
Article 1. General Provisions ― 1 ― Article 1. General Provisions 1. General Principles This Food Code shall be principally interpreted and applied by general provisions, except as otherwise specified. 1) This Food Code contains the following items. (1) Standard about methods of manufacturing, processing, using, cooking, storing foods and specification about food components under the regulations of Paragraph 1 in Article 7 of Food Sanitation Act. (2) Standard about manufacturing methods of utensil, container, packaging and specification about utensil, container, packaging and their raw materials under the regulations of Paragraph 1 in Article 9 of Food Sanitation Act. (3) Labeling standard about food, food additives, utensil, container, packaging and GMO under the regulations of Paragraph 1 in Article 10 of Food Sanitation Act. 2) Weights and measures shall be applied by the metric system and are indicated in following codes. (1) Length : m, cm, mm,μ m, nm (2)Volume:L,mL,μ L (3)Weight : kg, g, mg,μ g, ng, pg (4) Area : cm 2 (5) Calorie : kcal, kj 3) Weight percentage is indicated with the symbol of %. However, material content (g) in 100 mL solution is indicated with w/v% and material content (mL) in 100 mL solution with v/v%. Weight parts per million may be indicated with the symbol of mg/kg, ppm, or mg/L. 4) Temperature indication adopts Celsius(℃ ) type. 5) Standard temperature is defined as 20℃ , and ordinary temperature as 15~25 ℃ , and room temperature as 1~3 5℃ , and slightly warm temperature as 30~40℃ . 6) Except as otherwise specified, cold water is defined as waterof15℃ orlower,hotwater aswaterof60~70 ℃ , boiling water as water of about 100℃ , and heating temperature "in/under water bath" is, except as otherwise specified, defined as about 100℃ and water bath can be replaced with steam bath of about 100℃ . -
Phenylpropanoids
Phenylpropanoids The phenylpropanoids are a diverse family of organic compounds that are synthesized by plants from the amino acids phenylalanine and tyrosine. Their name is derived from the six-carbon, aromatic phenyl group and the three-carbon propene tail of cinnamic acid, which is synthesized from phenylalanine in the first step of phenylpropanoid biosynthesis. Phenylpropanoids are found throughout the plant kingdom, where they serve as essential components of a number of structural polymers, provide protection from ultraviolet light, defend against herbivores and pathogens, and mediate plant-pollinator interactions as floral pigments and scent compounds. Concentrations of phenylpropanoids within plants are also altered by changes in resource availability. www.MedChemExpress.com 1 Phenylpropanoids Inhibitors & Modulators (+)-Columbianetin (+)-Columbianetin acetate ((S)-Columbianetin) Cat. No.: HY-N0363 ((S)-Columbianetin acetate) Cat. No.: HY-N0363A (+)-Columbianetin is an isomer of Columbianetin. (S)-Columbianetin acetate is an isomer of Columbianetin is a phytoalexin associated with Columbianetin. Columbianetin is a phytoalexin celery (Apium graveolens) resistance to associated with celery (Apium graveolens) pathogens during storage. Columbianetin exhibits resistance to pathogens during storage. excellent anti-fungal and anti-inflammatory Columbianetin exhibits excellent anti-fungal and activity. anti-inflammatory activity. Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 5 mg, 10 mg, 20 mg Size: 5 mg, 10 mg, 20 mg (+)-Guaiacin (+)-Peusedanol Cat. No.: HY-N2247A Cat. No.: HY-N6063 (+)-Guaiacin is a compound extracted of the bark (+)-Peusedanol is a coumarin isolated from of Machilus wangchiana Chun. (Lauraceae). Peucedanumjaponicum. (+)-Guaiacin shows potent in vitro activities against the release of β-glucuronidase in rat polymorphonuclear leukocytes (PMNs) induced by platelet-activating factor (PAF) . -
Ornamental Plants in Different Approaches
Ornamental Plants in Different Approaches Assoc. Prof. Dr. Arzu ÇIĞ cultivation sustainibility ecology propagation ORNAMENTAL PLANTS IN DIFFERENT APPROACHES EDITOR Assoc. Prof. Dr. Arzu ÇIĞ AUTHORS Atilla DURSUN Feran AŞUR Husrev MENNAN Görkem ÖRÜK Kazım MAVİ İbrahim ÇELİK Murat Ertuğrul YAZGAN Muhemet Zeki KARİPÇİN Mustafa Ercan ÖZZAMBAK Funda ANKAYA Ramazan MAMMADOV Emrah ZEYBEKOĞLU Şevket ALP Halit KARAGÖZ Arzu ÇIĞ Jovana OSTOJIĆ Bihter Çolak ESETLILI Meltem Yağmur WALLACE Elif BOZDOGAN SERT Murat TURAN Elif AKPINAR KÜLEKÇİ Samim KAYIKÇI Firat PALA Zehra Tugba GUZEL Mirjana LJUBOJEVIĆ Fulya UZUNOĞLU Nazire MİKAİL Selin TEMİZEL Slavica VUKOVIĆ Meral DOĞAN Ali SALMAN İbrahim Halil HATİPOĞLU Dragana ŠUNJKA İsmail Hakkı ÜRÜN Fazilet PARLAKOVA KARAGÖZ Atakan PİRLİ Nihan BAŞ ZEYBEKOĞLU M. Anıl ÖRÜK Copyright © 2020 by iksad publishing house All rights reserved. No part of this publication may be reproduced, distributed or transmitted in any form or by any means, including photocopying, recording or other electronic or mechanical methods, without the prior written permission of the publisher, except in the case of brief quotations embodied in critical reviews and certain other noncommercial uses permitted by copyright law. Institution of Economic Development and Social Researches Publications® (The Licence Number of Publicator: 2014/31220) TURKEY TR: +90 342 606 06 75 USA: +1 631 685 0 853 E mail: [email protected] www.iksadyayinevi.com It is responsibility of the author to abide by the publishing ethics rules. Iksad Publications – 2020© ISBN: 978-625-7687-07-2 Cover Design: İbrahim KAYA December / 2020 Ankara / Turkey Size = 16 x 24 cm CONTENTS PREFACE Assoc. Prof. Dr. Arzu ÇIĞ……………………………………………1 CHAPTER 1 DOUBLE FLOWER TRAIT IN ORNAMENTAL PLANTS: FROM HISTORICAL PERSPECTIVE TO MOLECULAR MECHANISMS Prof. -
Trans-Resveratrol [501-36-0]
trans-Resveratrol [501-36-0] Review of Toxicological Literature March 2002 trans-Resveratrol [501-36-0] Review of Toxicological Literature Prepared for Scott Masten, Ph.D. National Institute of Environmental Health Sciences P.O. Box 12233 Research Triangle Park, North Carolina 27709 Contract No. N01-ES-65402 Submitted by Karen E. Haneke, M.S. Integrated Laboratory Systems P.O. Box 13501 Research Triangle Park, North Carolina 27709 March 2002 Toxicological Summary for trans-Resveratrol [501-36-0] 03/2002 Executive Summary Nomination trans-Resveratrol was nominated for toxicology studies by the National Institute of Environmental Health Sciences (NIEHS) based on the widespread human exposure to resveratrol through natural dietary sources and dietary supplement use, and concern that it has not been sufficiently evaluated for potential toxicological effects. Non-Toxicological Data General Description: trans-Resveratrol is a polyphenol that occurs naturally in grapes, peanuts, and a number of other plants. It is found in foods/drinks made from grapes and peanuts, and also in a number of herbal remedies, both alone and as part of plant extracts. Commercial Availability, Production, and Uses: trans-Resveratrol is produced commercially by several companies. A commercial extraction method involves using alcohol and water to produce trans resveratrol from Polygonum cuspidatum. Resveratrol compounds may be produced or extracted for research purposes by treating cell suspension cultures of grapes with a natural substance from a fungus. Resveratrol compounds have long been found in herbal medicines. Health claims of oral dietary supplements containing trans-resveratrol include protection from free-radical damage, inhibition of arthritic inflammation, inhibition of the cyclooxygenase-2 enzyme, protection of blood vessels, protection against cardiovascular disease and cancer, and alleviation of menopausal symptoms. -
Urinary and Serum Concentrations of Seven Phytoestrogens in a Human Reference Population Subset
Journal of Exposure Analysis and Environmental Epidemiology (2003) 13, 276–282 r 2003 Nature Publishing Group All rights reserved 1053-4245/03/$25.00 www.nature.com/jea Urinary and serum concentrations of seven phytoestrogens in a human reference population subset LIZA VALENTI´ N-BLASINI, BENJAMIN C. BLOUNT, SAMUEL P. CAUDILL, AND LARRY L. NEEDHAM National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA Diets rich in naturally occurring plant estrogens (phytoestrogens) are strongly associated with a decreased risk for cancer and heart disease in humans. Phytoestrogens have estrogenic and, in some cases, antiestrogenic and antiandrogenic properties, and may contribute to the protective effect of some diets. However, little information is available about the levels of these phytoestrogens in the general US population. Therefore, levels of phytoestrogenswere determined in urine (N ¼ 199) and serum (N ¼ 208) samples taken from a nonrepresentative subset of adults who participated in NHANES III, 1988– 1994. The phytoestrogens quantified were the lignans (enterolactone, enterodiol, matairesinol); the isoflavones (genistein, daidzein, equol, O- desmethylangolensin); and coumestrol (urine only). Phytoestrogens with the highest mean urinary levels were enterolactone (512 ng/ml), daidzein(317 ng/ ml), and genistein (129 ng/ml). In serum, the concentrations were much less and the relative order was reversed, with genistein having the highest mean level (4.7 ng/ml), followed by daidzein (3.9 ng/ml) and enterolactone (3.6 ng/ml). Highly significant correlations of phytoestrogen levels in urineand serum samples from the same persons were observed for enterolactone, enterodiol, genistein, and daidzein. Determination of phytoestrogen concentrations in large study populations will give a better insight into the actual dietary exposure to these biologically active compounds in the US population. -
(12) Patent Application Publication (10) Pub. No.: US 2008/0261896 A1 Tanaka Et Al
US 20080261896A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0261896 A1 Tanaka et al. (43) Pub. Date: Oct. 23, 2008 (54) TESTOSTERONE GENERATING AND Publication Classification METABOLIZING ENHANCER (51) Int. Cl. (75) Inventors: Junji Tanaka, Aichi-pref (JP); A63L/70 (2006.01) Hiroshi Shi-Moda, Aichi-pref (JP); A6IP3/00 (2006.01) Shao-Jie Shan, Aichi-pref (JP); (52) U.S. Cl. .......................................................... S14/25 Hiromichi Murai, Aichi-pref (JP) (57) ABSTRACT Correspondence Address: A testosterone generating and metabolizing enhancer is pro BACON & THOMAS, PLLC posed in the invention, which increases concentrations of 625 SLATERS LANE, FOURTH FLOOR testosterone in both seminal vesicle and bloodstream, and ALEXANDRIA, VA 22314-1176 (US) may further promote the gene expression of metabolizing testosterone into 5C.-reductase of dihydrotestosterone. The (73) Assignee: Sinphar Pharmaceutical Co., testosterone generating and metabolizing enhancer of the Ltd., I Lan (TW) invention is characterized in that an effective component (21) Appl. No.: 12/081,147 thereof may be phenylethanoid glycosides; said phenyletha noid glycosides may comprise at least one of echinacoside (22) Filed: Apr. 11, 2008 and acteoside, or may comprise both echinacoside and acteo side, more preferably. The testosterone generating and (30) Foreign Application Priority Data metabolizing enhancer of the invention may be applied in medicines, Substances for external uses on skin, and foods Apr. 11, 2007 (JP) ................................. 2007-103561 and beverages for mammals (including humans); as well as an May 12, 2007 (JP) ................................. 2007-127458 animal feed for mammals. Patent Application Publication Oct. 23, 2008 Sheet 1 of 4 US 2008/0261896 A1 &&&&&&&&&&&&&&&&&& aaaaaaaaaaaaaaaaaaaaaaaaassessssssssssssss v.v.a. -
Analytical Reference Standards
Cerilliant Quality ISO GUIDE 34 ISO/IEC 17025 ISO 90 01:2 00 8 GM P/ GL P Analytical Reference Standards 2 011 Analytical Reference Standards 20 811 PALOMA DRIVE, SUITE A, ROUND ROCK, TEXAS 78665, USA 11 PHONE 800/848-7837 | 512/238-9974 | FAX 800/654-1458 | 512/238-9129 | www.cerilliant.com company overview about cerilliant Cerilliant is an ISO Guide 34 and ISO 17025 accredited company dedicated to producing and providing high quality Certified Reference Standards and Certified Spiking SolutionsTM. We serve a diverse group of customers including private and public laboratories, research institutes, instrument manufacturers and pharmaceutical concerns – organizations that require materials of the highest quality, whether they’re conducing clinical or forensic testing, environmental analysis, pharmaceutical research, or developing new testing equipment. But we do more than just conduct science on their behalf. We make science smarter. Our team of experts includes numerous PhDs and advance-degreed specialists in science, manufacturing, and quality control, all of whom have a passion for the work they do, thrive in our collaborative atmosphere which values innovative thinking, and approach each day committed to delivering products and service second to none. At Cerilliant, we believe good chemistry is more than just a process in the lab. It’s also about creating partnerships that anticipate the needs of our clients and provide the catalyst for their success. to place an order or for customer service WEBSITE: www.cerilliant.com E-MAIL: [email protected] PHONE (8 A.M.–5 P.M. CT): 800/848-7837 | 512/238-9974 FAX: 800/654-1458 | 512/238-9129 ADDRESS: 811 PALOMA DRIVE, SUITE A ROUND ROCK, TEXAS 78665, USA © 2010 Cerilliant Corporation. -
1.25 Lignans: Biosynthesis and Function
1.25 Lignans: Biosynthesis and Function NORMAN G. LEWIS and LAURENCE B. DAVIN Washington State University, Pullman, WA, USA 0[14[0 INTRODUCTION 539 0[14[1 DEFINITION AND NOMENCLATURE 539 0[14[2 EVOLUTION OF THE LIGNAN PATHWAY 531 0[14[3 OCCURRENCE 534 0[14[3[0 Li`nans in {{Early|| Land Plants 534 0[14[3[1 Li`nans in Gymnosperms and An`iosperms "General Features# 536 0[14[4 OPTICAL ACTIVITY OF LIGNAN SKELETAL TYPES AND LIMITATIONS TO THE FREE RADICAL RANDOM COUPLING HYPOTHESIS 536 0[14[5 707? STEREOSELECTIVE COUPLING] DIRIGENT PROTEINS AND E!CONIFERYL ALCOHOL RADICALS 541 0[14[5[0 Diri`ent Proteins Stipulate Stereoselective Outcome of E!Coniferyl Alcohol Radical Couplin` in Pinoresinol Formation 541 0[14[5[1 Clonin` of the Gene Encodin` the Diri`ent Protein and Recombinant Protein Expression in Heterolo`ous Systems 543 0[14[5[2 Sequence Homolo`y Comparisons 543 0[14[5[3 Comparable Systems 543 0[14[5[4 Perceived Biochemical Mechanism of Action 546 0[14[6 PINORESINOL METABOLISM AND ASSOCIATED METABOLIC PROCESSES 547 0[14[6[0 Sesamum indicum] "¦#!Piperitol\ "¦#!Sesamin\ and "¦#!Sesamolinol Synthases 547 0[14[6[1 Magnolia kobus] Pinoresinol and Pinoresinol Monomethyl Ether O!Methyltransferase"s# 550 0[14[6[2 Forsythia intermedia and Forsythia suspensa 551 0[14[6[2[0 "¦#!Pinoresinol:"¦#!lariciresinol reductase 552 0[14[6[2[1 "−#!Secoisolariciresinol dehydro`enase 554 0[14[6[2[2 Matairesinol O!methyltransferase 556 0[14[6[3 Linum usitatissimum] "−#!Pinoresinol:"−#!Lariciresinol Reductase and "¦#!Secoisolariciresinol Glucosyltransferase"s# 557 -
Thème Les Plantes Du Genre Petasites; Effets Toxiques Et Cibles
ﺟـــﺎﻣﻌــــﺔ ﻣﺤﻤﺪ اﻟﺼﺪﯾﻖ ﺑﻦ ﯾﺤــﯿــــــــﻰ ﺟﯿـﺠـــﻞ ﻛﻠﯾ ـ ﺔ ﻋ ـــــ ﻠوم اﻟط ـــ ﺑﯾﻌ ـ ﺔ واﻟﺣــــــﯾﺎة Faculté des Sciences de la Nature et de la ﻗﺳ ــــــ م : اﻟﺑﯾوﻟوﺟﯾﺎ اﻟﺟزﯾﺋﯾﺔ واﻟﺧﻠوﯾﺔ Vie Département : Biologie M o léculaire et Cellulaire Mémoire de Master Filière : Sciences Biologiques Option : Toxicologie Fondamentale et Appliquée Thème Les plantes du genre Petasites ; effets toxiques et cibles thérapeutiques Membres deJury : Présenté par : Président e : D r BOULASSEL A. AZIROU Nour - djihan e Examinatrice : D r CHERBEL A. HAMRIT Mounira Promotrice : M me BENHAMADA N. SAHEL Imane Année Universitaire 20 1 9 - 20 20 Numéro d’ordre ( bibliothèque ) : …………… Remerciements Nous remercions d’abord ALLAH le Tout - Puissant de nous avoir accordé la santé et le courage pour accomplir ce travail. Nous remercions chaleureusement notre promotrice M me BENHAMADA N. enseignante à l’Université Mohamed Seddik Be n Ya hia pour avoir accepté de diriger ce travail. Qu’elle soit également remerciée pour sa disponibilité permanente, son aide, et ses précieux conseils. Nos remerciements s’adressent également à tous les membres de jury : la présidente D r. BO ULASSEL A. et l’ex aminatrice Dr. CHERBEL A., d’avoir accepté d’examiner ce travail. Nous remercions tout particulièrement nos familles pour leur soutien et leur encouragement durant ce parcours. Et à toute personne qui a contribué de près ou de loin à l’é laboration de notre travail Sommaire Liste des a bréviations Liste des figures Liste des tableaux Introduction générale ................................ ................................ ................................ ............................ 1 C hapitre I. Les plantes du genre Petasites I.1. Généralités ................................ ................................ ................................ ................................ ..... 4 I.1.1 .